SEC Form 4 · accession 0001645627-18-000034
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 13, 2018
Accepted (ET)
Jun 19, 2018 · 3:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2018 | P | 1,000 | $0.0393 | A | 25,156,289 | D | |
| Common Stock | Jun 13, 2018 | P | 1,000 | $0.0389 | A | 25,157,289 | D | |
| Common Stock | Jun 13, 2018 | P | 1,000 | $0.0377 | A | 25,158,289 | D | |
| Common Stock | Jun 13, 2018 | P | 1,000 | $0.0377 | A | 25,159,289 | D | |
| Common Stock | Jun 14, 2018 | P | 1,000 | $0.0359 | A | 25,160,289 | D | |
| Common Stock | Jun 14, 2018 | P | 1,000 | $0.0359 | A | 25,161,289 | D | |
| Common Stock | Jun 14, 2018 | P | 1,000 | $0.0359 | A | 25,162,289 | D | |
| Common Stock | Jun 14, 2018 | P | 1,000 | $0.0385 | A | 25,163,289 | D |
Table II — derivative securities
No Table II lines on this filing.